Individual differences in the development of uncontrollable fear in response to traumatic stressors have been observed in clinic,but the underlying mechanisms remain unknown.In the present study we first conducted a meta-analysis of published clinical data and found that malondialdehyde,an oxidative stress biomarker,was significantly elevated in the blood of patients with fear-related anxiety disorders.We then carried out experimental study in rats subjected to fear conditioning.We showed that reestablishing redox homeostasis in basolateral amygdale(BLA)after exposure to fear stressors determined the capacity of learned fear inhibition.Intra-BLA infusion of buthionine sulfoximine(BSO)to deplete the most important endogenous antioxidant glutathione(GSH)blocked fear extinction,whereas intra-BLA infusion of dithiothreitol or N-acetylcysteine(a precursor of GSH)facilitated extinction.In electrophysiological studies conducted on transverse slices,we showed that fear stressors induced redox-dependent inhibition of NMDAR-mediated synaptic function,which was rescued by extinction learning or reducing agents.Our results reveal a novel pharmacological strategy for reversing impaired fear inhibition and highlight the role of GSH in the treatment of psychiatric disorders.